Targeted and Immunotherapies in BRAF Mutant Melanoma Targeted and Immunotherapies in BRAF Mutant Melanoma

Review the clinical considerations for choosing between MAPK inhibitors and immune checkpoint inhibitors as first-line therapy for BRAF mutant advanced melanoma.The British Journal of Dermatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news